NCT06683261View on ClinicalTrials.gov

Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 23, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)Chronic Rhinosinusitis (CRS)
Interventions
BIOLOGICAL

Omalizumab

biological prescribed as add-on treatment as part of the standard of care

BIOLOGICAL

Dupilumab

biological prescribed as add-on treatment as part of the standard of care

BIOLOGICAL

Mepolizumab 100 mg

biological prescribed as add-on treatment as part of the standard of care

Trial Locations (8)

1090

RECRUITING

University Hospital Brussels, Jette

1200

RECRUITING

University hospital Saint-Luc, Brussels

2650

RECRUITING

University hospital of Antwerp, Edegem

3000

RECRUITING

University hospitals Leuven, Leuven

3600

RECRUITING

Hospital Zuid-Oost Limburg, Genk

4000

RECRUITING

CHU de Liège, Liège

8000

RECRUITING

General hospital Sint-Jan Bruges, Bruges

9300

RECRUITING

Onze Lieve Vrouw hospital Aalst, Aalst

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER